Advances of biofilm-inspired nanotechnologies for targeted lung cancer treatment
New Medicine · 2025
DOI: 10.61958/nmcl1884 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Medicine, 2025.
Abstract (Originalsprache)
Lung cancer is the leading cause of cancer-related deaths worldwide, driving the search for advanced therapeutic strategies. Biomimetic nanocarriers derived from cell membranes, often associated with biofilm-like properties, are emerging as powerful tools for targeted drug delivery and immune modulation in the tumor microenvironment. This review delineates the definition and classification of biofilms, explores their biological interactions with lung cancer, and highlights their diagnostic and therapeutic applications. We further examine how nano-bioengineering enhances these platforms and discuss the interplay between lung microbiota and biofilms in cancer progression. By integrating insights from nanotechnology, microbiology, and oncology, this review provides a unique perspective on next-generation precision strategies for lung cancer treatment, which is beneficial for the understanding of bacterial biofilm as a biocarrier in the treatment of lung cancer.
Zitieren
APA
(2025). Advances of biofilm-inspired nanotechnologies for targeted lung cancer treatment. New Medicine. https://doi.org/10.61958/nmcl1884
Vancouver
Advances of biofilm-inspired nanotechnologies for targeted lung cancer treatment. New Medicine. 2025. doi:10.61958/nmcl1884
BibTeX
@article{euvimed2025,
title = {Advances of biofilm-inspired nanotechnologies for targeted lung cancer treatment},
journal = {New Medicine},
year = {2025},
doi = {10.61958/nmcl1884}
}
EUVIMED